Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amalia M Issa

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Nature Reviews. Drug Discovery|July 18, 2002
Ethical perspectives on pharmacogenomic profiling in the drug development processAmalia M Issa
Mcgill Journal of Medicine : MJM : an International Forum for the Advancement of Medical Sciences by Students|June 5, 2008
Personalized medicine and the practice of medicine in the 21st centuryAmalia M Issa
Personalized Medicine|May 17, 2018
10 years of personalizing medicine: how the incorporation of genomic information is changing practice and policyAmalia M Issa
Journal of the American Geriatrics Society|May 25, 2002
Taking off the white coat: can family members who are physicians be good surrogate decision-makers?Amalia M Issa
Pharmacogenomics|August 29, 2003
Pharmacogenomic profiling in postmarketing surveillance: prospects and challengesAmalia M Issa
Clinical Pharmacology in Drug Development|September 2, 2025
Pharma's AI Inflection Point: What Does It Mean for Early Phase Clinical Development?Amalia M Issa
Current Topics in Medicinal Chemistry|September 24, 2004
The regulation of pharmacogenomics-based drugs and policy makingAmalia M Issa
Clinical Pharmacology in Drug Development|April 1, 2026
Are We Overstudying Biosimilars? Re-Centering Clinical Pharmacology in the Demonstration of SimilarityAmalia M Issa
Clinical Pharmacology in Drug Development|July 31, 2025
Editorial: Early Phase Innovation-Adapting to the New Age of Accelerated Drug ApprovalsAmalia M Issa
Expert Review of Clinical Pharmacology|January 16, 2014
Clinical applications of pharmacogenomics to adverse drug reactionsAmalia M Issa
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Nature Reviews. Drug Discovery|July 18, 2002
Ethical perspectives on pharmacogenomic profiling in the drug development processAmalia M Issa
Mcgill Journal of Medicine : MJM : an International Forum for the Advancement of Medical Sciences by Students|June 5, 2008
Personalized medicine and the practice of medicine in the 21st centuryAmalia M Issa
Personalized Medicine|May 17, 2018
10 years of personalizing medicine: how the incorporation of genomic information is changing practice and policyAmalia M Issa
Journal of the American Geriatrics Society|May 25, 2002
Taking off the white coat: can family members who are physicians be good surrogate decision-makers?Amalia M Issa
Pharmacogenomics|August 29, 2003
Pharmacogenomic profiling in postmarketing surveillance: prospects and challengesAmalia M Issa
Clinical Pharmacology in Drug Development|September 2, 2025
Pharma's AI Inflection Point: What Does It Mean for Early Phase Clinical Development?Amalia M Issa
Current Topics in Medicinal Chemistry|September 24, 2004
The regulation of pharmacogenomics-based drugs and policy makingAmalia M Issa
Clinical Pharmacology in Drug Development|April 1, 2026
Are We Overstudying Biosimilars? Re-Centering Clinical Pharmacology in the Demonstration of SimilarityAmalia M Issa
Clinical Pharmacology in Drug Development|July 31, 2025
Editorial: Early Phase Innovation-Adapting to the New Age of Accelerated Drug ApprovalsAmalia M Issa
Expert Review of Clinical Pharmacology|January 16, 2014
Clinical applications of pharmacogenomics to adverse drug reactionsAmalia M Issa
Pageof 6